Clinical Trials
3
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)iLux Treatment for Meibomian Gland Dysfunction (MGD)
Not Applicable
Completed
- Conditions
- Evaporative Dry Eye
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Tear Film Innovations, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03055650
- Locations
- 🇺🇸
TearFilm Investigative Site, San Diego, California, United States
Comparison Between iLux™ and LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Not Applicable
Completed
- Conditions
- Meibomian Gland Dysfunction
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Tear Film Innovations, Inc.
- Target Recruit Count
- 142
- Registration Number
- NCT03055832
- Locations
- 🇺🇸
TearFilm Investigative Site, Kansas City, Missouri, United States
Tear Film Innovations iLux Safety Study
Not Applicable
Completed
- Conditions
- Evaporative Dry EyeMeibomian Gland Dysfunction
- First Posted Date
- 2017-02-16
- Last Posted Date
- 2023-04-12
- Lead Sponsor
- Tear Film Innovations, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT03055897
- Locations
- 🇺🇸
TearFilm Innovations Investigative Site, Encinitas, California, United States
News
No news found